NCT05161182

Brief Summary

Diet and nutrition are key to maintain human health. Westlake N-of-1 Trials for Macronutrient Intake (WE-MACNUTR) trial investigates individualized postprandial glycemic responses to different proportions of dietary fat and carbohydrates intake using an n-of-1 experimental study design. The experimental diets are isocaloric high fat, low carbohydrate (HF-LC) or low fat, high carbohydrate (LF-HC). With standardized intervention and strictly controlled eating behaviors, the WE-MACNUTR study identifies specific HC-responders and HF-responders in terms of postprandial glucose response. This is a follow-up study offered to participants who have completed the WE-MACNUTR study in 2019. Volunteers will be asked to participate in four 5-d periods while wearing glucose monitors (Abbott Freestyle Libre) with the following experimental sequence: 1) a washout diet, 2) HF-LC or LC-HF diet, 3) a washout diet, 4) HF-LC or LC-HF diet. The experimental diet will be randomly assigned. Participants will be asked to provide a fasted blood sample and to collect fecal, urine and saliva samples at each visits.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 30, 2021

Completed
19 days until next milestone

First Submitted

Initial submission to the registry

November 18, 2021

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 18, 2021

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 19, 2021

Completed
28 days until next milestone

First Posted

Study publicly available on registry

December 17, 2021

Completed
Last Updated

June 1, 2022

Status Verified

October 1, 2021

Enrollment Period

19 days

First QC Date

November 18, 2021

Last Update Submit

May 27, 2022

Conditions

Keywords

Personalized NutritionGlucose MetabolismGut Microbiota

Outcome Measures

Primary Outcomes (1)

  • Blood glucose profiling

    Real-time blood glucose fluctuations will be recorded by CGM.

    20 days

Other Outcomes (6)

  • Urines untargeted metabolomics profiling

    Day 6, day 11 day 16 and day 21 of the study

  • Fecal targeted metabolomics profiling

    Day 6, day 11 day 16 and day 21 of the study

  • Microbiome taxonomic profiling

    Day 6, day 11 day 16 and day 21 of the study

  • +3 more other outcomes

Study Arms (2)

High fat, low carbohydrate diet

EXPERIMENTAL
Other: High fat, low carbohydrate diet

Low fat, high carbohydrate diet

EXPERIMENTAL
Other: Low fat, high carbohydrate diet

Interventions

Throughout the 5-day intervention, participants are provided with a high fat, low carbohydrate (HF-LC) diet in which the percentage of fat, protein and carbohydrate is 60%, 15% and 25%, respectively.

Also known as: HF-LC
High fat, low carbohydrate diet

Throughout the 5-day intervention, participants are provided with a low fat, high carbohydrate (LF-HC) diet in which the percentage of fat, protein and carbohydrate is 10%, 15% and 75%, respectively.

Also known as: LF-HC
Low fat, high carbohydrate diet

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Participants have completed WE-MACNUTR trial in 2019
  • Participants have no traveling plans within 1 months
  • Participants are able and willing to comply with the study protocol and provide informed consent

You may not qualify if:

  • Refuse or are unable to provide informed consent to participate in the study
  • Have long-term gastrointestinal diseases and take daily relevant medications
  • Have taken antibiotics in the last 2 weeks
  • Have type 2 diabetes and are taking medications or other treatments
  • Have chronic or acute liver disease and are taking medications or other treatments
  • Have cardiovascular diseases and are taking medications or other treatments
  • Have kidney disease and are taking medications
  • Suffer from chronic anxiety or depression, or other critical neuronal disorder and/or history of relevant medication
  • Are pregnant or lactating, or are planning to be pregnant in the next 3 months
  • Diagnosed with an eating disorder (e.g. anorexia nervosa or bulimia nervosa)
  • Are vegan, or unwilling to consume foods provided in the study
  • Have history of alcohol or drug addiction, or smoke above 15 cigarettes per day

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Westlake University

Hangzhou, Zhejiang, 310024, China

Location

MeSH Terms

Conditions

HyperglycemiaGlucose Metabolism Disorders

Interventions

Diet, Carbohydrate-RestrictedDiet, Fat-Restricted

Condition Hierarchy (Ancestors)

Metabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Diet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Ju-Sheng Zheng, PhD

    Westlake University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 18, 2021

First Posted

December 17, 2021

Study Start

October 30, 2021

Primary Completion

November 18, 2021

Study Completion

November 19, 2021

Last Updated

June 1, 2022

Record last verified: 2021-10

Locations